Unmet Needs and Harm Reduction Preferences of Syringe Services Program Participants: Differences by Co-use of Illicit Opioids and Methamphetamine

Overview

Journal Harm Reduct J

Publisher Biomed Central

Specialties Pharmacology
Psychiatry

Date 2024 Jun 18

PMID 38890736

Authors

Rachel Sun

Tonazzina H Sauda

Rachel A Hoopsick

Affiliations

Soon will be listed here.

Abstract

Background: The current fourth wave of the United States opioid overdose epidemic is characterized by the co-use of opioids and stimulants, including illicit opioids and methamphetamine. The co-use of these two drugs, known as "goofballing," is associated with higher risk for several adverse outcomes, including more frequent injections, greater health risks, and higher morbidity. Considering these differences, this unique subpopulation of people who inject drugs (PWID) may also have unique unmet needs and harm reduction preferences.

Methods: We collected self-reported data from participants (N = 50) of a syringe services program (SSP), including basic needs and harm reduction preferences. Using bivariate analyses, we examined differences between SSP participants who do and do not co-use illicit opioids and methamphetamine. Co-use was defined as reporting the use of both drugs, which may or may not have been used simultaneously.

Results: In the overall sample, the mean level of need was highest for bus passes or other transportation, a person who can help you get the services you need, medication for opioid use disorder, and a job or job training. Additionally, all participants reported being either interested or very interested in fentanyl test strips, safe consumption sites, delivery of syringe service supplies, and delivery of naloxone. Those who endorsed co-use had a greater need for food, healthcare, substance use disorder treatment, a support person to help them access needed services, and bus passes or transportation.

Conclusions: Unmet needs were prevalent, and the desire for more harm reduction services was high among these PWID. Results also suggest people who co-use illicit opioids and methamphetamine may have the greatest unmet needs and desire for additional harm reduction services.

References

Ashford R, Brown A, Dorney G, McConnell N, Kunzelman J, McDaniel J . Reducing harm and promoting recovery through community-based mutual aid: Characterizing those who engage in a hybrid peer recovery community organization. Addict Behav. 2019; 98:106037. PMC: 6708724. DOI: 10.1016/j.addbeh.2019.106037. View

Glick S, Klein K, Tinsley J, Golden M . Increasing Heroin-Methamphetamine (Goofball) Use and Related Morbidity Among Seattle Area People Who Inject Drugs. Am J Addict. 2020; 30(2):183-191. PMC: 8629025. DOI: 10.1111/ajad.13115. View

Korthuis P, Cook R, Foot C, Leichtling G, Tsui J, Stopka T . Association of Methamphetamine and Opioid Use With Nonfatal Overdose in Rural Communities. JAMA Netw Open. 2022; 5(8):e2226544. PMC: 9379740. DOI: 10.1001/jamanetworkopen.2022.26544. View

Hazani H, Naina Mohamed I, Muzaimi M, Mohamed W, Yahaya M, Teoh S . Goofballing of Opioid and Methamphetamine: The Science Behind the Deadly Cocktail. Front Pharmacol. 2022; 13:859563. PMC: 9021401. DOI: 10.3389/fphar.2022.859563. View

Dai Z, Abate M, Groth C, Rucker T, Kraner J, Mock A . Fentanyl and other opioid involvement in methamphetamine-related deaths. Am J Drug Alcohol Abuse. 2021; 48(2):226-234. DOI: 10.1080/00952990.2021.1981919. View

Jenkins R . The fourth wave of the US opioid epidemic and its implications for the rural US: A federal perspective. Prev Med. 2021; 152(Pt 2):106541. DOI: 10.1016/j.ypmed.2021.106541. View

Palmer A, Higgs P, Scott N, Agius P, Maher L, Dietze P . Prevalence and correlates of simultaneous, multiple substance injection (co-injection) among people who inject drugs in Melbourne, Australia. Addiction. 2020; 116(4):876-888. DOI: 10.1111/add.15217. View

Estadt A, White B, Ricks J, Lancaster K, Hepler S, Miller W . The impact of fentanyl on state- and county-level psychostimulant and cocaine overdose death rates by race in Ohio from 2010 to 2020: a time series and spatiotemporal analysis. Harm Reduct J. 2024; 21(1):13. PMC: 10792830. DOI: 10.1186/s12954-024-00936-9. View

Ciccarone D . The triple wave epidemic: Supply and demand drivers of the US opioid overdose crisis. Int J Drug Policy. 2019; 71:183-188. PMC: 6675668. DOI: 10.1016/j.drugpo.2019.01.010. View

10.

Hedegaard H, Minino A, Warner M . Co-involvement of Opioids in Drug Overdose Deaths Involving Cocaine and Psychostimulants. NCHS Data Brief. 2021; (406):1-8. View

11.

Brener L, Caruana T, Broady T, Cama E, Ezard N, Madden A . Addressing injecting related risks among people who inject both opioids and stimulants: Findings from an Australian survey of people who inject drugs. Addict Behav Rep. 2022; 15:100398. PMC: 8717740. DOI: 10.1016/j.abrep.2021.100398. View

12.

Zoorob M . Fentanyl shock: The changing geography of overdose in the United States. Int J Drug Policy. 2019; 70:40-46. DOI: 10.1016/j.drugpo.2019.04.010. View

13.

Ciccarone D . Fentanyl in the US heroin supply: A rapidly changing risk environment. Int J Drug Policy. 2017; 46:107-111. PMC: 5742018. DOI: 10.1016/j.drugpo.2017.06.010. View

14.

Kawasaki S, Francis E, Mills S, Buchberger G, Hogentogler R, Kraschnewski J . Multi-model implementation of evidence-based care in the treatment of opioid use disorder in Pennsylvania. J Subst Abuse Treat. 2019; 106:58-64. PMC: 7194237. DOI: 10.1016/j.jsat.2019.08.016. View

15.

Hoopsick R, Yockey R . Methamphetamine-Related Mortality in the United States: Co-Involvement of Heroin and Fentanyl, 1999-2021. Am J Public Health. 2023; 113(4):416-419. PMC: 10003484. DOI: 10.2105/AJPH.2022.307212. View

16.

Kandel D, Huang F, Davies M . Comorbidity between patterns of substance use dependence and psychiatric syndromes. Drug Alcohol Depend. 2001; 64(2):233-41. DOI: 10.1016/s0376-8716(01)00126-0. View

17.

Eddie D, Hoffman L, Vilsaint C, Abry A, Bergman B, Hoeppner B . Lived Experience in New Models of Care for Substance Use Disorder: A Systematic Review of Peer Recovery Support Services and Recovery Coaching. Front Psychol. 2019; 10:1052. PMC: 6585590. DOI: 10.3389/fpsyg.2019.01052. View

18.

Godkhindi P, Nussey L, OShea T . "They're causing more harm than good": a qualitative study exploring racism in harm reduction through the experiences of racialized people who use drugs. Harm Reduct J. 2022; 19(1):96. PMC: 9406271. DOI: 10.1186/s12954-022-00672-y. View

19.

Des Jarlais D, Nugent A, Solberg A, Feelemyer J, Mermin J, Holtzman D . Syringe Service Programs for Persons Who Inject Drugs in Urban, Suburban, and Rural Areas - United States, 2013. MMWR Morb Mortal Wkly Rep. 2015; 64(48):1337-41. DOI: 10.15585/mmwr.mm6448a3. View

20.

Friedman J, Shover C . Charting the fourth wave: Geographic, temporal, race/ethnicity and demographic trends in polysubstance fentanyl overdose deaths in the United States, 2010-2021. Addiction. 2023; 118(12):2477-2485. DOI: 10.1111/add.16318. View